Effects of long-term treatment with resveratrol and subcutaneous and oral estradiol administration on the pituitary-thyroid-axis

Experimental and Clinical Endocrinology and Diabetes

Volumn 114, Issue 2, 2006, Pages 82-90

  Böttner, Martina ^a   Christoffel, J ^b   Rimoldi, G ^b   Wuttke, W ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Estrogen; Phytoestrogen; T3; T4; TSH

Indexed keywords

ESTRADIOL; RESVERATROL; THYROTROPIN; THYROXINE;

ADENOHYPOPHYSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; FEMALE; GRAPE; HEART PROTECTION; HYPOPHYSIS; LONG TERM CARE; NONHUMAN; PEANUT; PRIORITY JOURNAL; RAT; RED WINE; THYROID GLAND;

ADMINISTRATION, ORAL; ANIMAL FEED; ANIMALS; ARACHIS HYPOGAEA; CARDIOTONIC AGENTS; CELL CULTURE TECHNIQUES; ESTRADIOL; FEMALE; INJECTIONS, SUBCUTANEOUS; NEUROSECRETORY SYSTEMS; OVARIECTOMY; PITUITARY GLAND; RATS; RATS, SPRAGUE-DAWLEY; STILBENES; THYROID GLAND; THYROTROPIN, BETA SUBUNIT; VASODILATOR AGENTS; WINE;

EID: 33645451791     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-923888     Document Type: Article

References (64)

1. Anderson JJ, Garner SC. Phytoestrogens and bone. Bailleres Clin Endocrinol Metab 1998; 12: 543-557
2. Ashby J, Tinwell H, Pennie W, Brooks AN, Lefevre PA, Beresford N, Sumpter JP. Partial and weak oestrogenicity of the red wine constituent resveratrol: consideration of its superagonist activity in MCF-7 cells and its suggested cardiovascular protective effects. J Appl Toxicol 1999; 19: 39-45
3. Bagchi D, Das DK, Tosaki A, Bagchi M, Kothari SC. Benefits of resveratrol in women's health. Drugs Exp Clin Res 2001; 27: 233-248
4. Bartalena L, Robbins J. Variations in thyroid hormone transport proteins and their clinical implications. Thyroid 1992; 2: 237-245
5. Baur A, Bauer K, Jarry H, Köhrle J. Effects of proinflammatory cytokines on anterior pituitary 5′-deiodinase type I and type II. J Endocrinol 2000; 167: 505-515
6. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 419-427
7. Bhat KP, Lantvit D, Christov K, Mehta RG, Moon RC, Pezzuto JM. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res 2001; 61: 7456-7463
8. Bhat KP, Pezzuto JM. Cancer chemopreventive activity of resveratrol. Ann NY Acad Sci 2002; 957: 210-229
9. Bi XL, Yang JY, Dong YX, Wang JM, Cui YH, Ikeshima T, Zhao YQ, Wu CF. Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia. Int Immunopharmacol 2005; 5: 185-193
10. Böttner M, Wuttke W. Chronic treatment with low doses of estradiol affects pituitary and thyroid function in young and middle-aged ovariectomized rats. Biogerontology 2005; 6: 261-269
11. Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM. Resveratrol acts as a mixed agonist/antagonist for estrogen receptor alpha and beta. Endocrinology 2000; 141: 3657-3667
12. Burger H. Hormone replacement therapy in the post-Women's Health Initiative era. Report of a meeting held in Funchal, Madeira, February 24-25, 2003. Climacteric 2003; 6 (Suppl 1): 11-36
13. Cadenas S, Barja G. Resveratrol, melatonin, vitamin E, and PBN protect against renal oxidative DNA damage induced by the kidney carcinogen KBrO3. Free Radic Biol Med 1999; 26: 1531-1537
14. Carlson HE, Jacobs LS, Daughaday WH. Growth hormone, thyrotropin, and prolactin responses to thyrotropin-releasing hormone following diethylstilbestrol pre-treatment. J Clin Endocrinol Metab 1973; 37: 488-490
15. Chen HJ, Walfish PG. Effects of estradiol benzoate on thyroid-pituitary function in female rats. Endocrinology 1978; 103: 1023-1030
16. Chiechi LM. Dietary phytoestrogens in the prevention of long-term postmenopausal diseases. Int J Gynaecol Obstet 1999; 39-40
17. Chiechi LM, Lobascio A, Grillo A, Valerio T. Phytoestrogen-containing food and prevention of postmenopausal osteoporosis and cardiovascular diseases. Minerva Ginecol 1999; 51: 343-348
18. D'Angelo SA, Fisher JS. Influence of estrogen on the pituitary-thyroid system of the female rat: mechanisms and loci of action. Endocrinology 1969; 84: 117-122
19. Davies PH, Sheppard MC, Franklyn JA. Inflammatory cytokines and type I 5′-deiodinase expression in phi1 rat liver cells. Mol Cell Endocrinol 1997; 129: 191-198
20. De Leo V, Lanzetta D, Vanni AL, D'Antona D, Severi FM. Low estrogen oral contraceptives and the hypothalamo-pituitary axis. Contraception 1991; 44: 155-161
21. Donnelly LE, Newton R, Kennedy GE, Fenwick PS, Leung RH, Ito K, Russell RE, Barnes PJ. Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am J Physiol Lung Cell Mol Physiol 2004; 287: 1774-1783
22. Dubal DB, Kashon ML, Pettigrew LC, Ren JM, Finklestein SP, Rau SW, Wise PM. Estradiol protects against ischemic injury. J Cereb Blood Flow Metab 1998; 18: 1253-1258
23. ElAttar TM, Virji AS. Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation. Anticancer Drugs 1999; 10: 187-193
24. Faglia G, Beck-Peccoz P, Ferrari C, Ambrosi B, Spada A, Travaglini P. Enhanced plasma thyrotrophin response to thyrotrophin-releasing hormone following oestradiol administration in man. Clin Endocrinol (Oxf) 1973; 2: 207-210
25. Fantz CR, Dagogo-Jack S, Ladenson JH, Gronowski AM. Thyroid function during pregnancy. Clin Chem 1999; 45: 2250-2258
26. Farbota L, Hofmann C, Oslapas R, Paloyan E. Sex hormone modulation of serum TSH levels. Surgery 1987; 102: 1081-1087
27. Fisher JS, D'Angelo SA. Stimulatory and inhibitory action of estradiol on TSH secretion. Endocrinology 1971; 88: 687-691
28. Foster JS, Wimalasena J. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells. Mol Endocrinol 1996; 10: 488-498
29. Freyberger A, Hartmann E, Hildebrand H, Krotlinger F. Differential response of immature rat uterine tissue to ethinylestradiol and the red wine constituent resveratrol. Arch Toxicol 2001; 74: 709-715
30. Fujii T, Sato K, Ozawa M, Kasono K, Imamura H, Kanaji Y, Tsushima T, Shizume K. Effect of interleukin-1 (IL-1) on thyroid hormone metabolism in mice: stimulation by IL-1 of iodothyronine 5′-deiodinating activity (type I) in the liver. Endocrinology 1989; 124: 167-174
31. Furlanetto TW, Nguyen LQ, Jameson JL. Estradiol increases proliferation and downregulates the sodium/idodide symporter gene in FRTL-5 cells. Endocrinology 1999; 140: 5705-5711
32. Gehm BD, McAndrews JM, Chien PY, Jameson JL. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA 1997; 94: 14138-14143
33. Glinoer D. What happens to the normal thyroid during pregnancy? Thyroid 1999; 9: 631-635
34. Gual C, Kastin AJ, Schally AV. Clinical experience with hypothalamic releasing hormones. 1. Thytrotropin-releasing hormone. Recent Prog Horm Res 1972; 28: 173-200
35. Hashimoto H, Igarashi N, Miyawaki T, Sato T. Effects of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 on type I iodothyronine 5′-deiodination in rat thyroid cell line, FRTL-5. J Interferon Cytokine Res 1995; 15: 367-375
36. Henderson BE, Ross RK, Pike MC, Casagrande JT. Endogenous hormones as a major factor in human cancer. Cancer Res 1982; 42: 3232-3239
37. Herrington DM. The HERS trial results: paradigms lost? Heart and Estrogen/progestin Replacement Study. Ann Intern Med 1999; 131: 463-466
38. Inoue H, Oshimo K, Kawano M, Monden Y. Immunohistochemical study of estrogen receptors and the responsiveness to estrogen in papillary thyroid carcinoma. Cancer 1993; 72: 1364-1368
39. Jakobs TC, Mentrup B, Schmutzler C, Dreher I, Köhrle J. Proinflammatory cytokines inhibit the expression and function of human type I 5′-deiodinase in HepG2 hepatocarcinoma cells. Eur J Endocrinol 2002; 146: 559-566
40. Köhrle J. Thyroid hormone deiodination in target tissues - a regulatory role for the trace element selenium? Exp Clin Endocrinol 1994; 102: 63-89
41. Kuhl H, Gahn G, Romberg G, Althoff PH, Taubert HD. A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic serum parameters: II. Effects upon thyroid function, gastrin, STH, and glucose tolerance. Contraception 1985; 32: 97-107
42. Leung BS, Potter AH. Mode of estrogen action on cell proliferative kinetics in CAMA-1 cells. I. Effect of serum and estrogen. Cancer Investigation 1987; 5: 187-194
43. Lin JK, Tsai SH. Chemoprevention of cancer and cardiovascular disease by resveratrol. Proc Natl Sci Counc Repub China B 1999; 23: 99-106
44. Manole D, Schildknecht B, Gosnell B, Adams E, Derwahl M. Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metabol 2001; 86: 1072-1077
45. McElduff A. Measurement of free thyroxine (T4) levels in pregnancy. Aust NZ J Obstet Gynaecol 1999; 39: 158-161
46. Meng Y, Ma QY, Kou XP, Xu J. Effect of resveratrol on activation of nuclear factor kappa B and inflammatory factors in rat model of acute pancreatitis. World J Gastroenterol 2005; 11: 525-528
47. Moreira RM, Lisboa PC, Curty FH, Pazos-Moura CC. Dose-dependent effects of 17-beta-estradiol on pituitary thyrotropin content and secretion in vitro. Braz J Med Biol Res 1997; 30: 1129-1134
48. Mortimer CH, Besser GM, Goldie DJ, Hook J, McNeilly AS. The TSH, FSH and prolactin responses to continuous infusions of TRH and the effects of oestrogen administration in normal males. Clin Endocrinol (Oxf) 1074; 3: 97-103
49. Olas B, Wachowicz B, Saluk-Juszczak J, Zeilinski T. Effect of resveratrol, a natural polyphenolic compound, on platelet activation induced by endotoxin or thrombin. Thromb Res 2002; 107: 141-145
50. Pang XP, Hershman JM, Mirell CJ, Pekary AE. Impairment of hypothalamic-pituitary-thyroid function in rats treated with human recombinant tumor necrosis factor-alpha (cachectin). Endocrinology 1989; 125: 76-84
51. Ramey JN, Burrow GN, Polackwich RJ, Donabedian RK. The effect of oral contraceptive steroids on the response of thyroid-stimulating hormone to thyrotropin-releasing hormone. J Clin Endocrinol Metab 1975; 40: 712-714
52. Ramsey LA, Ross BS, Fischer RG. Phytoestrogens and the management of menopause. Adv Nurse Pract 1999; 7: 26-30
53. Rastogi GK, Dash RJ, Sinha MK. Thyrotropin releasing hormone induced thyrotropin release in euthyroid men. Effect of ethinyl oestradiol priming. Indian J Med Sci 1974; 28: 529-531
54. Roth C, Schricker M, Lakomek M, Strege A, Heiden I, Luft H, Munzel U, Wuttke W, Jarry H. Autoregulation of the gonadotropin-releasing hormone (GnRH) system during puberty: effects of antagonistic versus agonistic GnRH analogs in a female rat model. J Endocrinol 2001; 169: 361-371
55. Sato M, Maulik N, Das DK. Cardioprotection with alcohol; role of both alcohol and polyphenolic antioxidants. Ann NY Acad Sci 2002; 957: 122-135
56. Sawhney RC, Rastogi I, Rastogi GK. Effect of estrogens on thyroid function. I. Alterations in rhesus plasma thyrotropin and its kinetics. Endocrinology 1978; 102: 1310-1316
57. Schlecht C, Klammer H, Jarry H, Wuttke W. Effects of estradiol, benzophenone-2 and benzophenone 3 on the expression pattern of the estrogen receptors (ER) alpha and beta, the estrogen receptor-related receptor 1 (ERR1) and the aryl hydrocarbon receptor (AhR) in adult ovariectomized rats. Toxicology 2004; 205: 123-130
58. Sosic-Jurjevic B, Filipovic B, Milosevic V, Nestorovic N, Manojlovic-Stojanoski M, Brkic B, Sekulic M. Chronic estradiol exposure modulates thyroid structure and decreases T4 and T3 serum levels in middle-aged female rats. Horm Res 2005; 63: 48-54
59. Spitz IM, Zylber-Haran EA, Trestian S. The thyrotropin (TSH) profile in isolated gonadotropin deficiency: a model to evaluate the effect of sex steroids on TSH secretion. J Clin Endocrinol Metab 1983; 57: 415-420
60. Tang YP, Haslam SZ, Conrad SE, Sisk CL. Estrogen increases brain expression of the mRNA encoding transthyretin, an amyloid beta scavenger protein. J Alzheimer's Disease 2004; 6: 413-420; discussion 443-449
61. Thomas DK, Storlien LH, Bellingham WP, Gillette K. Ovarian hormone effects on activity, glucoregulation and thyroid hormones in the rat. Physiol Behav 1986; 36: 567-573
62. Toldy E, Locsei Z, Rigo E, Kneffel P, Szabolcs I, Kovacs GL. Comparative analytical evaluation of thyroid hormone levels in pregnancy and in women taking oral contraceptives: a study from an iodine deficient area. Gynecol Endocrinol 2004; 18: 219-226
63. Turner RT, Evans GL, Zhang M, Maran A, Sibonga JD. Is resveratrol an estrogen agonist in growing rats? Endocrinology 1999; 140: 50-54
64. Yane K, Kitahori Y, Konishi N, Okaichi K, Ohnishi T, Miyahara H, Matsunaga T, Lin JC, Hiasa Y. Espression of the estrogen receptor in human thyroid neoplasms. Cancer Lett 1994; 84: 59-66